12 May 2026 · Virtual · Dr. Tomoko Xu, Universitätsklinikum Heidelberg · MSL Luis Ortega · Lumeva
No questions recorded.
Advisory board with primary care physician at Universitätsklinikum Heidelberg. Discussed dosing in hepatic impairment.
No insights captured from this engagement.
Review complete. Quality ratings and insights can now be used in aggregates.
No follow-ups recorded.
1–5, rated at review
All create, update and approval events for this record
No audit events in sample data